These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 3237679)

  • 21. Shapes of antibody binding sites: qualitative and quantitative analyses based on a geomorphic classification scheme.
    Lee M; Lloyd P; Zhang X; Schallhorn JM; Sugimoto K; Leach AG; Sapiro G; Houk KN
    J Org Chem; 2006 Jul; 71(14):5082-92. PubMed ID: 16808494
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Length of the antibody heavy chain complementarity determining region 3 as a specificity-determining factor.
    Barrios Y; Jirholt P; Ohlin M
    J Mol Recognit; 2004; 17(4):332-8. PubMed ID: 15227640
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Grafting of "abbreviated" complementarity-determining regions containing specificity-determining residues essential for ligand contact to engineer a less immunogenic humanized monoclonal antibody.
    De Pascalis R; Iwahashi M; Tamura M; Padlan EA; Gonzales NR; Santos AD; Giuliano M; Schuck P; Schlom J; Kashmiri SV
    J Immunol; 2002 Sep; 169(6):3076-84. PubMed ID: 12218124
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A common NH53K mutation in the combining site of antibodies raised against chlamydial LPS glycoconjugates significantly increases avidity.
    Blackler RJ; Müller-Loennies S; Brooks CL; Evans DW; Brade L; Kosma P; Brade H; Evans SV
    Biochemistry; 2011 Apr; 50(16):3357-68. PubMed ID: 21405106
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structural consequences of humanizing an antibody.
    Holmes MA; Foote J
    J Immunol; 1997 Mar; 158(5):2192-201. PubMed ID: 9036965
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization and molecular modeling of a highly stable anti-Hepatitis B surface antigen scFv.
    Bose B; Chugh DA; Kala M; Acharya SK; Khanna N; Sinha S
    Mol Immunol; 2003 Dec; 40(9):617-31. PubMed ID: 14597165
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of an anti-digoxin antibody binding site by site-directed in vitro mutagenesis.
    Near RI; Mudgett-Hunter M; Novotny J; Bruccoleri R; Ng SC
    Mol Immunol; 1993 Mar; 30(4):369-77. PubMed ID: 8455637
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of the fine specificity of anti-dinitrophenyl-combining site composed of either VL dimer or VL and VH of protein 315.
    Gavish M; Dwek RA; Givol D
    Biochemistry; 1977 Jul; 16(14):3154-9. PubMed ID: 70219
    [No Abstract]   [Full Text] [Related]  

  • 29. Humanization of a murine monoclonal antibody by simultaneous optimization of framework and CDR residues.
    Wu H; Nie Y; Huse WD; Watkins JD
    J Mol Biol; 1999 Nov; 294(1):151-62. PubMed ID: 10556035
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thermodynamic analysis of an antibody functional epitope.
    Kelley RF; O'Connell MP
    Biochemistry; 1993 Jul; 32(27):6828-35. PubMed ID: 7687461
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The advantage of protecting the antigen-binding site during antibody labeling.
    Krohn KA; Eary JF
    J Nucl Med; 1991 Jan; 32(1):122-3. PubMed ID: 1988615
    [No Abstract]   [Full Text] [Related]  

  • 32. The intrinsic cysteine and histidine residues of the anti-Salmonella antibody Se155-4: a model for the introduction of new functions into antibody-binding sites.
    Young NM; Watson DC; Cunningham AM; MacKenzie CR
    Protein Eng Des Sel; 2014 Oct; 27(10):383-90. PubMed ID: 24828819
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Humanization of a mouse monoclonal antibody by CDR-grafting: the importance of framework residues on loop conformation.
    Kettleborough CA; Saldanha J; Heath VJ; Morrison CJ; Bendig MM
    Protein Eng; 1991 Oct; 4(7):773-83. PubMed ID: 1798701
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Beyond CDR-grafting: Structure-guided humanization of framework and CDR regions of an anti-myostatin antibody.
    Apgar JR; Mader M; Agostinelli R; Benard S; Bialek P; Johnson M; Gao Y; Krebs M; Owens J; Parris K; St Andre M; Svenson K; Morris C; Tchistiakova L
    MAbs; 2016 Oct; 8(7):1302-1318. PubMed ID: 27625211
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stability improvement of antibodies for extracellular and intracellular applications: CDR grafting to stable frameworks and structure-based framework engineering.
    Ewert S; Honegger A; Plückthun A
    Methods; 2004 Oct; 34(2):184-99. PubMed ID: 15312672
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The increased flexibility of CDR loops generated in antibodies by Congo red complexation favors antigen binding.
    Krol M; Roterman I; Drozd A; Konieczny L; Piekarska B; Rybarska J; Spolnik P; Stopa B
    J Biomol Struct Dyn; 2006 Feb; 23(4):407-16. PubMed ID: 16363876
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bifunctional hybrids between the variable domains of an immunoglobulin and the maltose-binding protein of Escherichia coli: production, purification and antigen binding.
    Brégégère F; Schwartz J; Bedouelle H
    Protein Eng; 1994 Feb; 7(2):271-80. PubMed ID: 8170930
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antigen mobility in the combining site of an anti-peptide antibody.
    Cheetham JC; Raleigh DP; Griest RE; Redfield C; Dobson CM; Rees AR
    Proc Natl Acad Sci U S A; 1991 Sep; 88(18):7968-72. PubMed ID: 1716767
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Structure of antibodies and the specificity of the antigen-antibody interaction (author's transl)].
    Fiebig H
    Acta Histochem Suppl; 1980; 22():27-38. PubMed ID: 6166962
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional characterization of an anti-estradiol antibody by site-directed mutagenesis and molecular modelling: modulation of binding properties and prominent role of the V(L) domain in estradiol recognition.
    Coulon S; Pellequer JL; Blachère T; Chartier M; Mappus E; Chen Sw SW; Cuilleron CY; Baty D
    J Mol Recognit; 2002; 15(1):6-18. PubMed ID: 11870917
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.